Bright light exposure reduces TH-positive dopamine neurons: Implications of light pollution in Parkinson's disease epidemiology

Scientific Reports

Volumn 3, Issue , 2013, Pages

  Romeo, Stefania ^a   Viaggi, Cristina ^b   Di Camillo, Daniela ^a   Willis, Allison W ^c   Lozzi, Luca ^a   Rocchi, Cristina ^a   Capannolo, Marta ^a   Aloisi, Gabriella ^a   Vaglini, Francesca ^b   MacCarone, Rita ^a   Caleo, Matteo ^d   Missale, Cristina ^e   Racette, Brad A ^c   Corsini, Giovanni U ^b   Maggio, Roberto ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

^c WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CNR   (Italy)

^e UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; MELANIN; NEUROMELANIN; TYROSINE 3 MONOOXYGENASE;

ANIMAL; ARTICLE; DOPAMINERGIC NERVE CELL; ENVIRONMENTAL EXPOSURE; HUMAN; LIGHT; LUMINESCENCE; MALE; METABOLISM; OPTIC NERVE; PARKINSON DISEASE; PREVALENCE; RADIATION EXPOSURE; RAT; SUBSTANTIA NIGRA; UNITED STATES;

ANIMALS; DOPAMINERGIC NEURONS; ENVIRONMENTAL EXPOSURE; HUMANS; LIGHT; LUMINESCENCE; MALE; MELANINS; NEUROTRANSMITTER AGENTS; OPTIC NERVE; PARKINSON DISEASE; PREVALENCE; RATS; SUBSTANTIA NIGRA; TYROSINE 3-MONOOXYGENASE; UNITED STATES;

EID: 84875183835     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep01395     Document Type: Article

References (34)

1. Xuan, Q. et al. Increase expression of a-synuclein in aged human brain associated with neuromelanin accumulation. J. Neural. Transm. 118, 1575-1583 (2011).
2. Elsworth, J. D. & Roth, R. H. Dopamine synthesis, uptake, metabolism, and receptors: relevance to gene therapy of Parkinson's disease. Exp. Neurol. 144, 4-9 (1997). (Pubitemid 27149594)
3. Sulzer, D. & Zecca, L. Intraneuronal dopamine-quinone synthesis: a review. Neurotox. Res. 1, 181-195 (2000).
4. Bisaglia, M., Mamm, S. & Bubacco, L. Kinetic and structural analysis of the early oxidation products of dopamine: analysis of the interactions with a-synuclein. J. Biol. Chem. 282, 15597-15605 (2007). (Pubitemid 47093273)
5. Sulzer, D. et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc. Natl. Acad. Sci. USA. 97, 11869-11874 (2000).
6. Sánchez-Rivera, A. E. et al. Spectrophotometric study on the stability of dopamine and the determination of its acidity constants. Spectrochim. Acta. A. Mol. Biomol . Spectrosc. 59, 3193-3203 (2003).
7. Barreto, W. J., Barreto, S. R. G. & Silva, W. P. A study of the aerobic reaction between dopamine and Fe(III) in the presence of S2O3. Transition. Met. Chem. 34, 677-681 (2009).
8. Smith,M. Shedding light on the adult brain: a review of the clinical applications of near-infrared spectroscopy. Philos. Transact. A. Math. Phys. Eng. Sci . 369, 4452-4469 (2011).
9. Foster, R. G.&Follett, B. K. The involvement of a rhodopsin-like photopigment in the photoperiodic response of the Japanese quail. J. Comp. Physiol. A. Neuroethol. Sens. Neural. Behav. Physiol. 157, 519-528 (1985). (Pubitemid 16200602)
10. Nakane, Y. et al. A mammalian neural tissue opsin (Opsin 5) is a deep brain photoreceptor in birds. Proc. Natl. Acad. Sci. USA. 107, 15264-15268 (2010).
11. Van Brunt, E. E., Shepherd, M. D., Wall, J. R., Ganong, W. F. & Clegg, M. T. Penetration of light into the brain of mammals. Ann. N Y. Acad. Sci. 117, 217-224 (1964).
12. Schapira, A. H. & Jenner, P. Etiology and pathogenesis of Parkinson's disease. Mov. Disord. 26, 1049-1055 (2011).
13. Marsden, C. D. Pigmentation in the nucleus substantiae nigrae of mammals. J. Anat. 95, 256-261 (1961).
14. Willis, A. W., Evanoff, B. A., Lian, M., Criswell, S. R. & Racette, B. A. Geographic and ethnic variation in Parkinson disease: a population-based study of US Medicare beneficiaries. Neuroepidemiology. 34, 143-151 (2010).
15. DeMattei, M., Levi, A. C. & Fariello, R. G. Neuromelanic pigment in substantia nigra neurons of rats and dogs. Neurosci. Lett. 72, 37-42 (1986). (Pubitemid 17184913)
16. Kim, S. T., Choi, J. H., Kim, D. & Hwang, O. Increases in TH immunoreactivity, neuromelanin and degeneration in the substantia nigra of middle aged mice. Neurosci. Lett. 396, 263-268 (2006). (Pubitemid 43331043)
17. Graham, D. G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14, 633-643 (1978). (Pubitemid 8402469)
18. Lotharius, J. & Brundin, P. Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein. Nat. Rev. Neurosci. 3, 932-942 (2002).
19. LaVoie, M. J. & Hastings, T. G. Dopamine quinone formation and protein modification associated with the striatal neurotoxicity of methamphetamine: evidence against a role for extracellular dopamine. J. Neurosci. 19, 1484-1491 (1999). (Pubitemid 29088929)
20. Zecca, L. et al. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. J. Clin. Pathol: Mol. Pathol. 5, 414-418 (2001). (Pubitemid 34025257)
21. Dexter, D. T., Sian, J., Jenner, P. & Marsden, C. D. Implications of alterations in trace element levels in brain in Parkinson's disease and other neurological disorders affecting the basal ganglia. Adv. Neurol. 60, 273-281 (1993).
22. Sian-Hülsmann, J., Mandel, S., Youdim,M. B. &Riederer, P. The relevance of iron in the pathogenesis of Parkinson's disease. J. Neurochem. 118, 939-957 (2011).
23. Shaw, V. E. et al. Neuroprotection of midbrain dopaminergic cells in MPTPtreated mice after near-infrared light treatment. J. Comp. Neurol. 518, 25-40 (2010).
24. Abilio, V. C., Freitas, F. M., Dolnikoff,M. S. & Castrucci, A.M. L. Frussa-Filho, R. Effects of continuous exposure to light on behavioural dopaminergic supersensitivity. Biol. Psychiatry. 45, 1622-1629 (1999). (Pubitemid 29292837)
25. Khaldy, H. et al. Circadian rhythms of dopamine and dihydroxyphenyl acetic acid in the mouse striatum: effects of pinealectomy and of melatonin treatment. Neuroendocrinology. 75, 201-208 (2002). (Pubitemid 34253076)
26. Jöbsis, F. F. Noninvasive, infrared monitoring of cerebral and myocardial oxygen sufficiency and circulatory parameters. Science. 198, 1264-1267 (1977). (Pubitemid 8308546)
27. Betemps, E. J.&Buncher, C. R. Birthplace as a risk factor in motor neurone disease and Parkinson's disease. Int. J. Epidemiol. 22, 898-904 (1993).
28. Pugliatti, M., Sotgiu, S. & Rosati, G. The worldwide prevalence of multiple sclerosis. Clin. Neurol. Neurosurg. 104, 182-191 (2002). (Pubitemid 34792722)
29. Kurtzke, J. F. & Goldberg, I. D. Parkinsonism death rates by race, sex, and geography. Neurology. 38, 1558-1561 (1988).
30. Lux, W. E. & Kurtzke, J. F. Is Parkinson's disease acquired? Evidence from a geographic comparison with multiple sclerosis. Neurology. 37, 467-471 (1987). (Pubitemid 17031745)
31. Lilienfeld, D. E. et al. Parkinsonism death rates by race, sex and geography: a 1980s update. Neuroepidemiology. 9, 243-247 (1990).
32. Braak, H. et al. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol. Aging. 24, 197-211 (2003). (Pubitemid 36007810)
33. Vaglini, F., Fascetti, F., Fornai, F., Maggio, R. & Corsini, G. U. (1)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice. Brain. Res. 668, 194-203 (1994).
34. Viggiani, E., Ciesla, M.&Russo, O. L. The shielding power of the rat skull to visible light. Experientia. 26, 850-851 (1970).